Fresenius Medical Care Shares Fall on Lower US Volumes
FMC shares fell 6% as U.S. dialysis volumes declined for a second quarter. Revenue fell to 4.61 billion euros amid currency impacts and transformation costs.
Xurve View
Insights:
Xurve View
FRESENIUS MEDICAL CARE AG shares fell nearly 6% Tuesday morning after reporting a 0.4% decline in United States treatment volumes. This marks the second consecutive quarter of shrinking U.S. volumes for the Germany-based dialysis provider. Investors are weighing persistent volume weakness against the company's ongoing profitability overhaul and 2026 outlook confirmation.
